Literature DB >> 12228309

Candida-specific antibodies during experimental vaginal candidiasis in mice.

Karen L Wozniak1, Floyd L Wormley, Paul L Fidel.   

Abstract

Protective host defense mechanisms against vaginal Candida albicans infections are poorly understood. Although cell-mediated immunity (CMI) is the predominant host defense mechanism against most mucosal Candida infections, the role of CMI against vaginal candidiasis is uncertain, both in humans and in an experimental mouse model. The role of humoral immunity is equally unclear. While clinical observations suggest a minimal role for antibodies against vaginal candidiasis, an experimental rat model has provided evidence for a protective role for Candida-specific immunoglobulin A (IgA) antibodies. Additionally, Candida vaccination-induced IgM and IgG3 antibodies are protective in a mouse model of vaginitis. In the present study, the role of infection-induced humoral immunity in protection against experimental vaginal candidiasis was evaluated through the quantification of Candida-specific IgA, IgG, and IgM antibodies in serum and vaginal lavage fluids of mice with primary and secondary (partially protected) infection. In naïve mice, total, but not Candida-specific, antibodies were detected in serum and lavage fluids, consistent with lack of yeast colonization in mice. In infected mice, Candida-specific IgA and IgG antibodies were induced in serum with anamnestic responses to secondary infection. In lavage fluid, while Candida-specific antibodies were detectable, concentrations were extremely low with no anamnestic responses in mice with secondary infection. The incorporation of alternative protocols-including infections in a different strain of mice, prolongation of primary infection prior to secondary challenge, use of different enzyme-linked immunosorbent assay capture antigens, and concentration of lavage fluid-did not enhance local Candida-specific antibody production or detection. Additionally, antibodies were not removed from lavage fluids by being bound to Candida during infection. Together, these data suggest that antibodies are not readily present in vaginal secretions of infected mice and thus have a limited natural protective role against infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12228309      PMCID: PMC128320          DOI: 10.1128/IAI.70.10.5790-5799.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Langerhans cells and T lymphocyte subsets in the murine vagina and cervix.

Authors:  M B Parr; E L Parr
Journal:  Biol Reprod       Date:  1991-03       Impact factor: 4.285

2.  Local production of chemokines during experimental vaginal candidiasis.

Authors:  M Saavedra; B Taylor; N Lukacs; P L Fidel
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

3.  Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance.

Authors:  L Romani; S Mocci; C Bietta; L Lanfaloni; P Puccetti; F Bistoni
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

4.  Differential susceptibility of two species of macaques to experimental vaginal candidiasis.

Authors:  C Steele; M Ratterree; P L Fidel
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

Review 5.  Pathogenesis and treatment of recurrent vulvovaginal candidiasis.

Authors:  J D Sobel
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

6.  Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody.

Authors:  Y Han; M H Riesselman; J E Cutler
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

7.  Cytokine, chemokine and chemokine receptor mRNA expression in different strains of normal mice: implications for establishment of a Th1/Th2 bias.

Authors:  P C Charles; K S Weber; B Cipriani; C F Brosnan
Journal:  J Neuroimmunol       Date:  1999-12       Impact factor: 3.478

8.  CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance.

Authors:  L Romani; A Mencacci; E Cenci; R Spaccapelo; P Mosci; P Puccetti; F Bistoni
Journal:  J Immunol       Date:  1993-02-01       Impact factor: 5.422

9.  Epidemiology of vaginitis.

Authors:  H L Kent
Journal:  Am J Obstet Gynecol       Date:  1991-10       Impact factor: 8.661

10.  Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis.

Authors:  F P Heinzel; M D Sadick; S S Mutha; R M Locksley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

View more
  15 in total

1.  A new model of vaginal infection by Candida albicans in rats.

Authors:  Márcia A Carrara; Lucélia Donatti; Edílson Damke; Terezinha I E Svidizinski; Márcia E L Consolaro; Márcia R Batista
Journal:  Mycopathologia       Date:  2010-06-09       Impact factor: 2.574

2.  Intestinal colonization with Candida albicans and mucosal immunity.

Authors:  Xiao-Dong Bai; Xian-Hua Liu; Qing-Ying Tong
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

Review 3.  The protective role of immunoglobulins in fungal infections and inflammation.

Authors:  Sri Ramulu Elluru; Srini V Kaveri; Jagadeesh Bayry
Journal:  Semin Immunopathol       Date:  2014-11-18       Impact factor: 9.623

4.  Susceptibility to vaginal candidiasis under different conditions in mice.

Authors:  Juan Tan; Jiawen Li; Shanjuan Chen; Yan Wu; Fang T Qin; Juan Ding; Fei Cao; Shaoru Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

5.  Prospects for development of a vaccine to prevent and control vaginal candidiasis.

Authors:  Paul L Fidel; Jim E Cutler
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

6.  The role of Candida albicans NOT5 in virulence depends upon diverse host factors in vivo.

Authors:  Shaoji Cheng; Cornelius J Clancy; Mary Ann Checkley; Zongde Zhang; Karen L Wozniak; Kalpathi R Seshan; Hong Yan Jia; Paul Fidel; Garry Cole; M Hong Nguyen
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

7.  Vaginal yeast colonisation, prevalence of vaginitis, and associated local immunity in adolescents.

Authors:  M M Barousse; B J Van Der Pol; D Fortenberry; D Orr; P L Fidel
Journal:  Sex Transm Infect       Date:  2004-02       Impact factor: 3.519

8.  Immune Regulation and Its Role in the Pathogenesis of Candida Vaginitis.

Authors:  Paul L. Fidel
Journal:  Curr Infect Dis Rep       Date:  2003-12       Impact factor: 3.725

Review 9.  Novel Mechanism behind the Immunopathogenesis of Vulvovaginal Candidiasis: "Neutrophil Anergy".

Authors:  Junko Yano; Brian M Peters; Mairi C Noverr; Paul L Fidel
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

Review 10.  Candidiasis--do we need to fight or to tolerate the Candida fungus?

Authors:  M Raska; J Bĕláková; M Krupka; E Weigl
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.